Macular Masquerades
Date: 7/09/2022 (AEST)
Venue: The Maribyrnong Boathouse, 7 The Boulevard, Moonee Ponds, VIC, 3039
Provider: Novartis
Contact: Charlie Almond, [E] Charlie.almond@novartis.com, [P] 0481450278
Learning Objectives
- Confidently identify AMD, DMO, and CMO secondary to RVO on OCT
- Develop a differential for macular pathology as seen on OCT
- Identify signs on OCT which may suggest another cause of macular pathology other than AMD and DMO
- Understand causes and treatments of patients developing Diplopia post cataract surgery
- Develop a better understanding of assessment of the post-surgical socket in relation to enucleation with implant versus evisceration
- Develop a better understanding of assessment of the causes of discomfort and discharge and how these issues are treated
- Develop a better understanding of the psychological issues that patients have with their seeing eye and concerns about the cosmoses of the prosthesis
Max CPD hours awarded: 2.75
Session Information
Name |
---|
Macular Masquarades |
Clinical? |
Yes |
Interactive? |
Yes |
Therapeutic? |
No |
Duration of CPD Session/Module |
1 |
Duration of CPD Session/Module inclusive of Assessment Component |
1.25 |
Name |
---|
Diplopia Post-Cataract Surgery |
Clinical? |
Yes |
Interactive? |
Yes |
Therapeutic? |
No |
Duration of CPD Session/Module |
0.75 |
Duration of CPD Session/Module inclusive of Assessment Component |
1 |
Name |
---|
Artificial Eyes |
Clinical? |
Yes |
Interactive? |
Yes |
Therapeutic? |
No |
Duration of CPD Session/Module |
0.25 |
Duration of CPD Session/Module inclusive of Assessment Component |
0.5 |